We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLH icon
201
Clean Harbors
CLH
$16.3B
$1.55M 0.12%
7,877
+253
+3% +$55.4K
FISV
202
Fiserv Inc
FISV
$27.9B
$1.53M 0.12%
6,920
-5,182
-43% -$1.13M
GLPI icon
203
Gaming and Leisure Properties
GLPI
$12.8B
$1.51M 0.11%
29,580
+1,463
+5% +$71.9K
T icon
204
AT&T
T
$163B
$1.51M 0.11%
53,226
-65,288
-55% -$1.64M
WELL icon
205
Welltower
WELL
$171B
$1.49M 0.11%
9,715
-3,442
-26% -$490K
CART icon
206
Maplebear
CART
$11.8B
$1.49M 0.11%
37,302
+13,186
+55% +$586K
SMH icon
207
VanEck Semiconductor ETF
SMH
$71.8B
$1.48M 0.11%
6,992
+440
+7% +$105K
LITE icon
208
Lumentum
LITE
$69.3B
$1.48M 0.11%
23,712
+15,112
+176% +$1.16M
BBWI icon
209
Bath & Body Works
BBWI
$4.1B
$1.48M 0.11%
48,657
+13,961
+40% +$494K
CNNE icon
210
Cannae Holdings
CNNE
$649M
$1.47M 0.11%
80,032
+40,032
+100% +$755K
ALNY icon
211
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.46M 0.11%
5,408
+595
+12% +$153K
QRVO icon
212
Qorvo
QRVO
$8.74B
$1.44M 0.11%
19,875
+1,713
+9% +$130K
XLV icon
213
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
$1.43M 0.11%
+9,814
New +$1.43M
GERN icon
214
Geron
GERN
$949M
$1.42M 0.11%
895,025
+418,031
+88% +$1.02M
FLGT icon
215
Fulgent Genetics
FLGT
$527M
$1.42M 0.11%
83,811
+68,368
+443% +$1.16M
WBA
216
CALL
DELISTED
Walgreens Boots Alliance
WBA
$1.41M 0.11%
+126,400
New +$1.37M
IWM icon
217
PUT
iShares Russell 2000 ETF
IWM
$81.9B
$1.4M 0.11%
7,000
-44,600
-86% -$9.67M
DASH icon
218
DoorDash
DASH
$93.7B
$1.39M 0.11%
7,621
-1,314
-15% -$247K
BCS icon
219
Barclays
BCS
$94.1B
$1.38M 0.11%
90,086
+26,786
+42% +$401K
SWTX
220
DELISTED
SpringWorks Therapeutics
SWTX
$1.38M 0.1%
31,183
+14,746
+90% +$679K
FCX icon
221
Freeport-McMoran
FCX
$97.5B
$1.37M 0.1%
36,259
-14,237
-28% -$545K
IAI icon
222
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
$1.37M 0.1%
+9,767
New +$1.45M
MRSH
223
CALL
Marsh
MRSH
$91.5B
$1.37M 0.1%
+5,600
New +$1.27M
L icon
224
CALL
Loews
L
$23.6B
$1.36M 0.1%
+14,800
New +$1.27M
EQR icon
225
Equity Residential
EQR
$25.1B
$1.36M 0.1%
+18,957
New +$1.34M

Similar funds

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.